SamaCare Releases Q2 2026 Market Access Benchmarks for Medical Benefit Drugs
Source: PRNewswire· July 28, 2026
SynaBot summary
New data reveals prior authorization approval rates for medical benefit drugs averaged 76.5% in Q2 2026, with resolution taking just over two days. These benchmarks, excluding manufacturer support, highlight significant performance differences across medical specialties and insurance providers.
Key takeaways
- Prior authorization approval rates hit 76.5% without direct manufacturer aid.
- Average resolution time for prior authorizations was 2.09 days.
- Approval rates and timelines vary significantly by medical specialty.
- Payer differences substantially impact prior authorization outcomes.
Why it matters
Understanding these prior authorization benchmarks is crucial for healthcare professionals leveraging AI tools. It helps set realistic expectations for AI-assisted workflows, identify areas where AI can improve efficiency, and negotiate better service level agreements with AI vendors.
This story was reported by PRNewswire. Read the full original article:
Read on PRNewswire Try this on SynaBot
Related AI assistants, prompts, and tools from the SynaBot catalog.
AI Assistants
AI Tools
- Jasper MarketingJasper Marketing leverages AI to help marketing teams generate various types of content, from blog posts to social media updates. It's designed to maintain brand voice and optimize content for engagement and SEO.
- Zoom MarketingZoom Marketing offers AI-driven marketing automation tailored for SMBs, simplifying customer engagement and lead nurturing. It helps businesses grow with intelligent campaigns and insights.
- MarketMuseMarketMuse utilizes AI to analyze content performance and suggest improvements for SEO and content strategy. It helps create comprehensive, authoritative content that ranks high in search engines.
